ID VPREB_HUMAN Reviewed; 145 AA. AC P12018; B5MCG2; DT 01-OCT-1989, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2000, sequence version 2. DT 24-JAN-2024, entry version 192. DE RecName: Full=Immunoglobulin iota chain; DE AltName: Full=CD179 antigen-like family member A; DE AltName: Full=Protein VPreB1; DE AltName: Full=V(pre)B protein; DE Short=VpreB protein; DE AltName: CD_antigen=CD179a; DE Flags: Precursor; GN Name=VPREB1; Synonyms=VPREB; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=7935499; DOI=10.1016/0161-5890(94)90105-8; RA Guelpa-Fonlupt V., Bossy D., Alzari P., Fumoux F., Fougereau M., Schiff C.; RT "The human pre-B cell receptor: structural constraints for a tentative RT model of the pseudo-light (psi L) chain."; RL Mol. Immunol. 31:1099-1108(1994). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=9074928; DOI=10.1101/gr.7.3.250; RA Kawasaki K., Minoshima S., Nakato E., Shibuya K., Shintani A., RA Schmeits J.L., Wang J., Shimizu N.; RT "One-megabase sequence analysis of the human immunoglobulin lambda gene RT locus."; RL Genome Res. 7:250-261(1997). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84; RA Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A., RA Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J., RA Beare D.M., Dunham I.; RT "A genome annotation-driven approach to cloning the human ORFeome."; RL Genome Biol. 5:R84.1-R84.11(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=10591208; DOI=10.1038/990031; RA Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M., RA Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C., RA Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E., RA Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C., RA Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G., RA Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V., RA Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., RA Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A., RA Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C., RA Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E., RA Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F., RA Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M., RA Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A., RA Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D., RA Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., RA Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S., RA Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E., RA Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L., RA Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L., RA Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N., RA Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A., RA Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L., RA Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P., RA Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P., RA Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q., RA Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J., RA Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J., RA Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D., RA Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T., RA Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., RA Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., RA Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R., RA Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L., RA McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J., RA Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E., RA Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P., RA Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y., RA Wright H.; RT "The DNA sequence of human chromosome 22."; RL Nature 402:489-495(1999). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-139. RX PubMed=3258819; DOI=10.1002/j.1460-2075.1988.tb02789.x; RA Bauer S.R., Kudo A., Melchers F.; RT "Structure and pre-B lymphocyte restricted expression of the VpreB in RT humans and conservation of its structure in other mammalian species."; RL EMBO J. 7:111-116(1988). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [8] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 21-119 IN COMPLEX WITH IGLL1, RP SUBUNIT, AND DISULFIDE BOND. RX PubMed=17431183; DOI=10.1126/science.1139412; RA Bankovich A.J., Raunser S., Juo Z.S., Walz T., Davis M.M., Garcia K.C.; RT "Structural insight into pre-B cell receptor function."; RL Science 316:291-294(2007). RN [9] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 95-108, AND DISULFIDE BOND. RX PubMed=18287279; DOI=10.1110/ps.073269808; RA Morstadt L., Bohm A., Yuksel D., Kumar K., Stollar B.D., Baleja J.D.; RT "Engineering and characterization of a single chain surrogate light chain RT variable domain."; RL Protein Sci. 17:458-465(2008). CC -!- FUNCTION: Associates with the Ig-mu chain to form a molecular complex CC that is expressed on the surface of pre-B-cells. This complex CC presumably regulates Ig gene rearrangements in the early steps of B- CC cell differentiation. CC -!- SUBUNIT: Interacts with IGLL1 (PubMed:17431183). Interacts with CC SYNV1/HRD1 (via N-terminus); this interaction leads to increased VPREB1 CC ubiquitination and degradation in pre-B cells, possibly through a CC lysosomal, not proteasomal, pathway (By similarity). CC {ECO:0000250|UniProtKB:P13372, ECO:0000269|PubMed:17431183}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum CC {ECO:0000250|UniProtKB:P13372}. CC -!- TISSUE SPECIFICITY: Only expressed by pre-B-cells. CC -!- SIMILARITY: Belongs to the immunoglobulin superfamily. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Wikipedia; Note=VPREB1; CC URL="https://en.wikipedia.org/wiki/VPREB1"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; S74019; AAB32118.1; -; Genomic_DNA. DR EMBL; D86992; BAA19987.1; -; Genomic_DNA. DR EMBL; D88270; BAA20030.1; -; Genomic_DNA. DR EMBL; CR456609; CAG30495.1; -; mRNA. DR EMBL; CH471095; EAW59498.1; -; Genomic_DNA. DR EMBL; M34927; AAA61292.1; -; Genomic_DNA. DR CCDS; CCDS13798.1; -. DR PIR; I57832; I57832. DR PIR; S00258; S00258. DR RefSeq; NP_009059.1; NM_007128.3. DR PDB; 2H32; X-ray; 2.70 A; A=20-145. DR PDB; 2H3N; X-ray; 2.30 A; A/C=21-119. DR PDB; 3BJ9; X-ray; 2.00 A; 1=22-121. DR PDBsum; 2H32; -. DR PDBsum; 2H3N; -. DR PDBsum; 3BJ9; -. DR AlphaFoldDB; P12018; -. DR SMR; P12018; -. DR BioGRID; 113280; 1. DR CORUM; P12018; -. DR IntAct; P12018; 1. DR STRING; 9606.ENSP00000385361; -. DR iPTMnet; P12018; -. DR PhosphoSitePlus; P12018; -. DR BioMuta; VPREB1; -. DR DMDM; 9911096; -. DR PaxDb; 9606-ENSP00000385361; -. DR PeptideAtlas; P12018; -. DR ProteomicsDB; 52817; -. DR TopDownProteomics; P12018; -. DR Antibodypedia; 23612; 201 antibodies from 26 providers. DR DNASU; 7441; -. DR Ensembl; ENST00000403807.4; ENSP00000385361.3; ENSG00000169575.5. DR GeneID; 7441; -. DR KEGG; hsa:7441; -. DR MANE-Select; ENST00000403807.4; ENSP00000385361.3; NM_007128.4; NP_009059.1. DR UCSC; uc002zvx.2; human. DR AGR; HGNC:12709; -. DR CTD; 7441; -. DR DisGeNET; 7441; -. DR GeneCards; VPREB1; -. DR HGNC; HGNC:12709; VPREB1. DR HPA; ENSG00000169575; Tissue enriched (bone). DR MIM; 605141; gene. DR neXtProt; NX_P12018; -. DR OpenTargets; ENSG00000169575; -. DR PharmGKB; PA37324; -. DR VEuPathDB; HostDB:ENSG00000169575; -. DR eggNOG; ENOG502RTXJ; Eukaryota. DR GeneTree; ENSGT00940000161017; -. DR HOGENOM; CLU_077975_4_0_1; -. DR InParanoid; P12018; -. DR OMA; FYSIFWY; -. DR OrthoDB; 4068101at2759; -. DR PhylomeDB; P12018; -. DR TreeFam; TF352061; -. DR PathwayCommons; P12018; -. DR Reactome; R-HSA-202733; Cell surface interactions at the vascular wall. DR SignaLink; P12018; -. DR BioGRID-ORCS; 7441; 16 hits in 1138 CRISPR screens. DR EvolutionaryTrace; P12018; -. DR GeneWiki; VPREB1; -. DR GenomeRNAi; 7441; -. DR Pharos; P12018; Tbio. DR PRO; PR:P12018; -. DR Proteomes; UP000005640; Chromosome 22. DR RNAct; P12018; Protein. DR Bgee; ENSG00000169575; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 22 other cell types or tissues. DR ExpressionAtlas; P12018; baseline and differential. DR GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; IBA:GO_Central. DR GO; GO:0006955; P:immune response; IBA:GO_Central. DR Gene3D; 2.60.40.10; Immunoglobulins; 1. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003599; Ig_sub. DR InterPro; IPR013106; Ig_V-set. DR PANTHER; PTHR23267:SF11; IMMUNOGLOBULIN IOTA CHAIN; 1. DR PANTHER; PTHR23267; IMMUNOGLOBULIN LIGHT CHAIN; 1. DR Pfam; PF07686; V-set; 1. DR SMART; SM00409; IG; 1. DR SMART; SM00406; IGv; 1. DR SUPFAM; SSF48726; Immunoglobulin; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR Genevisible; P12018; HS. PE 1: Evidence at protein level; KW 3D-structure; Disulfide bond; Endoplasmic reticulum; Immunoglobulin domain; KW Reference proteome; Signal. FT SIGNAL 1..19 FT /evidence="ECO:0000255" FT CHAIN 20..145 FT /note="Immunoglobulin iota chain" FT /id="PRO_0000015000" FT DOMAIN 20..132 FT /note="Ig-like V-type" FT REGION 20..41 FT /note="Framework-1" FT REGION 42..56 FT /note="Complementarity-determining-1" FT REGION 57..70 FT /note="Framework-2" FT REGION 71..81 FT /note="Complementarity-determining-2" FT REGION 82..115 FT /note="Framework-3" FT REGION 121..145 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT DISULFID 41..115 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114, FT ECO:0000269|PubMed:17431183, ECO:0000269|PubMed:18287279" FT VARIANT 76 FT /note="D -> N (in dbSNP:rs1320)" FT /id="VAR_024503" FT VARIANT 122 FT /note="S -> L (in dbSNP:rs11089979)" FT /id="VAR_029133" FT VARIANT 132 FT /note="E -> K (in dbSNP:rs5995720)" FT /id="VAR_029134" FT CONFLICT 10 FT /note="L -> H (in Ref. 6; AAA61292)" FT /evidence="ECO:0000305" FT STRAND 22..24 FT /evidence="ECO:0007829|PDB:2H32" FT STRAND 27..32 FT /evidence="ECO:0007829|PDB:3BJ9" FT STRAND 37..43 FT /evidence="ECO:0007829|PDB:3BJ9" FT STRAND 45..47 FT /evidence="ECO:0007829|PDB:3BJ9" FT HELIX 49..51 FT /evidence="ECO:0007829|PDB:3BJ9" FT STRAND 54..59 FT /evidence="ECO:0007829|PDB:3BJ9" FT STRAND 66..73 FT /evidence="ECO:0007829|PDB:3BJ9" FT STRAND 76..79 FT /evidence="ECO:0007829|PDB:3BJ9" FT STRAND 87..92 FT /evidence="ECO:0007829|PDB:3BJ9" FT HELIX 93..95 FT /evidence="ECO:0007829|PDB:3BJ9" FT STRAND 97..102 FT /evidence="ECO:0007829|PDB:3BJ9" FT HELIX 107..109 FT /evidence="ECO:0007829|PDB:3BJ9" FT STRAND 111..117 FT /evidence="ECO:0007829|PDB:3BJ9" SQ SEQUENCE 145 AA; 16605 MW; 197665B13AF64D46 CRC64; MSWAPVLLML FVYCTGCGPQ PVLHQPPAMS SALGTTIRLT CTLRNDHDIG VYSVYWYQQR PGHPPRFLLR YFSQSDKSQG PQVPPRFSGS KDVARNRGYL SISELQPEDE AMYYCAMGAR SSEKEERERE WEEEMEPTAA RTRVP //